Get the Stockscreener App
2.03
5.18%
0.10
After Hours:
2.05
0.02
+0.99%
Shattuck Labs Inc stock is traded at $2.03, with a volume of 93,595.
It is up +5.18% in the last 24 hours and up +5.73% over the past month.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$1.93
Open:
$1.9
24h Volume:
93,595
Relative Volume:
0.14
Market Cap:
$128.46M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-1.0518
EPS:
-1.93
Net Cash Flow:
$-70.93M
1W Performance:
+7.98%
1M Performance:
+5.73%
6M Performance:
+89.72%
1Y Performance:
+100.99%
1-Day Range:
$1.89
$2.06
1-Week Range:
$1.855
$2.07
52-Week Range:
$0.6922
$2.705
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
2.03 | 122.13M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | Wedbush | Outperform |
| Mar-17-25 | Initiated | Leerink Partners | Outperform |
| Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-24 | Downgrade | Needham | Buy → Hold |
| Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
Long term hold vs stop loss in Shattuck Labs Inc.2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com
Why Shattuck Labs Inc. stock could see breakout soonOil Prices & Community Supported Trade Ideas - newser.com
Should I hold or sell Shattuck Labs Inc. stock in 2025Trade Analysis Report & Expert-Curated Trade Recommendations - newser.com
Shattuck Labs to Participate in Upcoming December Investor Conferences - The Manila Times
Shattuck Labs (NASDAQ: STTK) to Join Piper Sandler and Evercore December Events - Stock Titan
Shattuck Labs Reports Improved Financial Performance - MSN
Will Shattuck Labs Inc. stock recover faster than marketWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
CapEx per share of Shattuck Labs, Inc. – NASDAQ:STTK - TradingView
Is Shattuck Labs Inc. stock affected by interest rate hikesPortfolio Risk Report & Real-Time Market Trend Scan - newser.com
Will Shattuck Labs Inc. stock benefit from sector rotationJuly 2025 Gainers & Pattern Based Trade Signal System - newser.com
Shattuck Labs Inc. (STTK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Price action breakdown for Shattuck Labs Inc.2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Can technical indicators confirm Shattuck Labs Inc.’s reversalGlobal Markets & High Conviction Trade Alerts - newser.com
Volume spikes in Shattuck Labs Inc. stock – what they mean - newser.com
What moving averages say about Shattuck Labs Inc.Dollar Strength & AI Enhanced Execution Alerts - newser.com
Shattuck Labs (STTK) Price Target Increased by 12.50% to 3.06 - Nasdaq
Is Shattuck Labs Inc. stock attractive for income investors2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
How Shattuck Labs Inc. stock performs during Fed tightening cyclesJuly 2025 Decliners & Breakout Confirmation Alerts - newser.com
Will Shattuck Labs Inc. stock reach Wall Street targetsJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
How geopolitical tensions affect Shattuck Labs Inc. stockQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
Shattuck Labs, Inc.Common Stock (Nasdaq:STTK) Detailed Stock Data - FinancialContent
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):